Symbols / TFX Stock $136.56 -0.07% Teleflex Incorporated

Healthcare • Medical Instruments & Supplies • United States • NYQ
TFX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. Stuart A. Randle
Exch · Country NYQ · United States
Market Cap 6.04B
Enterprise Value 8.45B
Income 58.53M
Sales 1.99B
FCF (ttm) 12.83M
Book/sh 70.70
Cash/sh 9.16
Employees 15,500
Insider 10d —
IPO Mar 17, 1980
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 103.82%
P/E 104.24
Forward P/E 13.18
PEG 0.16
P/S 3.03
P/B 1.93
P/C —
EV/EBITDA 18.02
EV/Sales 4.24
Quick Ratio 0.98
Current Ratio 2.54
Debt/Eq 90.32
LT Debt/Eq —
EPS (ttm) 1.31
EPS next Y 10.37
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-02-26
ROA 2.59%
ROE 1.58%
ROIC —
Gross Margin 56.38%
Oper. Margin 40.56%
Profit Margin -45.45%
Shs Outstand 44.27M
Shs Float 44.03M
Insider Own 0.46%
Instit Own 110.04%
Short Float 8.39%
Short Ratio 3.38
Short Interest 2.43M
52W High 139.67
vs 52W High -2.23%
52W Low 100.18
vs 52W Low 36.31%
Beta 0.83
Impl. Vol. 62.15%
Rel Volume 0.80
Avg Volume 960.47K
Volume 768.77K
Target (mean) $132.78
Tgt Median $135.00
Tgt Low $115.00
Tgt High $147.00
# Analysts 9
Recom Hold
Prev Close $136.65
Price $136.56
Change -0.07%
About

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$132.78
Mean price target
2. Current target
$136.56
Latest analyst target
3. DCF / Fair value
$5.22
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$136.56
Low
$115.00
High
$147.00
Mean
$132.78

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-27 up Raymond James Market Perform → Outperform $128
2026-02-27 main RBC Capital Sector Perform → Sector Perform $125
2026-02-27 main Wells Fargo Equal-Weight → Equal-Weight $130
2026-02-26 main Needham Buy → Buy $147
2026-01-29 main Wells Fargo Equal-Weight → Equal-Weight $116
2026-01-27 up Needham Hold → Buy $138
2025-12-18 main Truist Securities Hold → Hold $135
2025-12-10 main Wells Fargo Equal-Weight → Equal-Weight $139
2025-11-10 main Truist Securities Hold → Hold $120
2025-11-07 main RBC Capital Sector Perform → Sector Perform $120
2025-11-07 main Wells Fargo Equal-Weight → Equal-Weight $114
2025-08-01 main Mizuho Neutral → Neutral $135
2025-08-01 main RBC Capital Sector Perform → Sector Perform $135
2025-08-01 main Wells Fargo Equal-Weight → Equal-Weight $131
2025-07-16 main Mizuho Neutral → Neutral $130
2025-07-15 main RBC Capital Sector Perform → Sector Perform $130
2025-05-05 main Truist Securities Hold → Hold $137
2025-05-05 main Morgan Stanley Overweight → Overweight $173
2025-05-02 main RBC Capital Sector Perform → Sector Perform $145
2025-05-02 main Wells Fargo Equal-Weight → Equal-Weight $137
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-03 HICKS CAMERON P Officer — 8,096 $0.00 $0
2026-03-03 DEREN JOHN Chief Financial Officer — 13,784 $0.00 $0
2026-03-03 WINTERS JAMES Officer — 13,007 $0.00 $0
2026-03-03 LOGUE DANIEL V. General Counsel — 9,853 $0.00 $0
2026-02-23 HICKS CAMERON P Officer — 352 $0.00 $0
2026-02-23 DEREN JOHN Chief Financial Officer — 161 $0.00 $0
2026-02-23 WINTERS JAMES Officer — 354 $0.00 $0
2026-02-23 LOGUE DANIEL V. General Counsel — 443 $0.00 $0
2026-01-13 RANDLE STUART A Chief Executive Officer — 12,325 $0.00 $0
2025-08-06 HAGGERTY GRETCHEN R Director — 500 $114.73 $57,375
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,992.71
+17.25%
1,699.55
-0.75%
1,712.44
-38.65%
2,791.04
Operating Revenue
1,992.71
+17.25%
1,699.55
-0.75%
1,712.44
-38.65%
2,791.04
Cost Of Revenue
871.96
+31.68%
662.16
-1.51%
672.33
-46.64%
1,259.95
Reconciled Cost Of Revenue
871.96
+31.68%
662.16
-1.51%
672.33
-46.64%
1,259.95
Gross Profit
1,120.75
+8.04%
1,037.39
-0.26%
1,040.11
-32.07%
1,531.09
Operating Expense
864.95
+10.39%
783.54
+6.41%
736.37
-27.63%
1,017.57
Research And Development
144.78
+32.80%
109.02
-4.05%
113.63
-26.13%
153.82
Selling General And Administration
720.17
+6.77%
674.52
+8.31%
622.74
-27.90%
863.75
Total Expenses
1,736.91
+20.14%
1,445.70
+2.63%
1,408.70
-38.15%
2,277.52
Operating Income
255.80
+0.77%
253.85
-16.43%
303.75
-40.85%
513.52
Total Operating Income As Reported
118.37
+14.20%
103.65
-59.94%
258.73
-48.23%
499.73
EBITDA
302.51
+11.49%
271.34
-35.17%
418.51
-42.73%
730.77
Normalized EBITDA
439.94
+4.37%
421.53
-9.06%
463.53
-37.78%
745.02
Reconciled Depreciation
177.74
+10.03%
161.53
+9.07%
148.10
-35.77%
230.59
EBIT
124.78
+13.64%
109.80
-59.39%
270.40
-45.94%
500.18
Total Unusual Items
-137.43
+8.50%
-150.19
-233.62%
-45.02
-215.95%
-14.25
Total Unusual Items Excluding Goodwill
-137.43
+8.50%
-150.19
-233.62%
-45.02
-215.95%
-14.25
Special Income Charges
-137.43
+8.50%
-150.19
-233.62%
-45.02
-215.95%
-14.25
Other Special Charges
—
132.73
+193.37%
45.24
+9865.64%
0.45
Impairment Of Capital Assets
—
240.00
0.00
0.00
Restructuring And Mergern Acquisition
29.31
+204.43%
9.63
+127.96%
4.22
-77.53%
18.80
Write Off
108.12
+1280.10%
7.83
0.00
-100.00%
1.50
Net Income
-905.64
-1399.81%
69.67
-80.45%
356.33
-1.88%
363.14
Pretax Income
24.55
-6.61%
26.29
-85.82%
185.39
-58.43%
445.92
Net Non Operating Interest Income Expense
-93.82
-21.28%
-77.36
-5.49%
-73.33
-37.46%
-53.35
Interest Expense Non Operating
100.22
+20.01%
83.51
-1.77%
85.01
+56.67%
54.26
Net Interest Income
-93.82
-21.28%
-77.36
-5.49%
-73.33
-37.46%
-53.35
Interest Expense
100.22
+20.01%
83.51
-1.77%
85.01
+56.67%
54.26
Interest Income Non Operating
6.40
+4.08%
6.15
-47.32%
11.68
+1180.59%
0.91
Interest Income
6.40
+4.08%
6.15
-47.32%
11.68
+1180.59%
0.91
Other Income Expense
-137.43
+8.50%
-150.19
-233.62%
-45.02
-215.95%
-14.25
Gain On Sale Of Business
—
0.00
-100.00%
4.45
-31.61%
6.50
Tax Provision
-33.98
-9.95%
-30.90
-173.80%
41.87
-49.55%
83.00
Tax Rate For Calcs
0.00
+0.00%
0.00
-7.02%
0.00
+21.34%
0.00
Tax Effect Of Unusual Items
-28.86
+8.50%
-31.54
-210.19%
-10.17
-283.38%
-2.65
Net Income Including Noncontrolling Interests
-905.64
-1399.81%
69.67
-80.45%
356.33
-1.88%
363.14
Net Income From Continuing Operation Net Minority Interest
58.53
+2.34%
57.19
-60.15%
143.52
-60.45%
362.92
Net Income From Continuing And Discontinued Operation
-905.64
-1399.81%
69.67
-80.45%
356.33
-1.88%
363.14
Net Income Continuous Operations
58.53
+2.34%
57.19
-60.15%
143.52
-60.45%
362.92
Net Income Discontinuous Operations
-964.17
-7823.25%
12.48
-94.13%
212.81
+95330.94%
0.22
Normalized Income
167.10
-4.97%
175.85
-1.41%
178.37
-52.37%
374.51
Net Income Common Stockholders
-905.64
-1399.81%
69.67
-80.45%
356.33
-1.88%
363.14
Diluted EPS
-20.30
-1471.62%
1.48
-80.35%
7.53
-1.95%
7.68
Basic EPS
-20.30
-1462.42%
1.49
-80.34%
7.58
-2.07%
7.74
Basic Average Shares
44.62
-4.73%
46.84
-0.31%
46.98
+0.18%
46.90
Diluted Average Shares
44.72
-5.03%
47.09
-0.44%
47.30
-0.01%
47.31
Diluted NI Availto Com Stockholders
-905.64
-1399.81%
69.67
-80.45%
356.33
-1.88%
363.14
Gain On Sale Of PPE
0.00
0.00
-100.00%
4.45
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
6,947.24
-2.12%
7,097.91
-5.77%
7,532.55
+8.73%
6,928.06
Current Assets
1,938.34
+31.76%
1,471.12
+4.53%
1,407.41
-0.25%
1,410.98
Cash Cash Equivalents And Short Term Investments
378.56
+52.74%
247.85
+11.22%
222.85
-23.69%
292.03
Cash And Cash Equivalents
378.56
+52.74%
247.85
+11.22%
222.85
-23.69%
292.03
Receivables
345.58
+52.42%
226.73
-48.87%
443.47
+8.47%
408.83
Accounts Receivable
345.58
+52.42%
226.73
-48.87%
443.47
+8.47%
408.83
Gross Accounts Receivable
349.58
+51.05%
231.43
-48.91%
452.97
+8.51%
417.43
Allowance For Doubtful Accounts Receivable
-4.00
+14.89%
-4.70
+50.53%
-9.50
-10.47%
-8.60
Inventory
404.39
+31.83%
306.77
-51.01%
626.22
+8.25%
578.51
Raw Materials
90.01
+28.45%
70.07
-60.97%
179.52
-3.82%
186.64
Work In Process
54.37
+44.22%
37.70
-66.08%
111.13
+12.26%
98.99
Finished Goods
260.02
+30.66%
199.00
-40.70%
335.57
+14.58%
292.87
Prepaid Assets
19.57
+465.98%
3.46
-53.31%
7.40
+13.49%
6.52
Assets Held For Sale Current
639.55
+9.41%
584.53
—
—
Other Current Assets
150.68
+48.03%
101.79
-5.29%
107.47
-14.08%
125.08
Total Non Current Assets
5,008.90
-10.98%
5,626.79
-8.14%
6,125.14
+11.02%
5,517.08
Net PPE
590.10
+46.00%
404.18
-33.02%
603.43
+4.33%
578.42
Gross PPE
1,060.15
+30.30%
813.60
-30.85%
1,176.60
+3.66%
1,135.10
Accumulated Depreciation
-470.06
-14.81%
-409.42
+28.57%
-573.16
-2.96%
-556.68
Properties
304.41
+65.71%
183.71
-35.45%
284.60
+4.41%
272.58
Machinery Furniture Equipment
532.84
+17.94%
451.79
-32.95%
673.84
+2.84%
655.23
Construction In Progress
131.09
+59.11%
82.39
-12.94%
94.63
+24.39%
76.08
Other Properties
91.82
-4.07%
95.71
-22.51%
123.52
-5.86%
131.21
Goodwill And Other Intangible Assets
3,829.20
+14.63%
3,340.60
-38.32%
5,416.02
+11.83%
4,842.90
Goodwill
2,305.05
+15.71%
1,992.18
-31.64%
2,914.05
+14.87%
2,536.73
Other Intangible Assets
1,524.15
+13.03%
1,348.42
-46.11%
2,501.96
+8.49%
2,306.16
Non Current Deferred Assets
12.59
+35.63%
9.29
+37.60%
6.75
+5.40%
6.40
Non Current Deferred Taxes Assets
12.59
+35.63%
9.29
+37.60%
6.75
+5.40%
6.40
Other Non Current Assets
577.01
-69.19%
1,872.73
+1792.74%
98.94
+10.72%
89.37
Total Liabilities Net Minority Interest
3,822.47
+35.56%
2,819.77
-8.79%
3,091.56
+6.38%
2,906.09
Current Liabilities
762.03
+17.35%
649.36
+7.02%
606.75
+4.34%
581.49
Payables And Accrued Expenses
396.51
+12.00%
354.03
-25.10%
472.70
+9.77%
430.61
Payables
148.99
+7.17%
139.02
-19.96%
173.70
+14.62%
151.54
Accounts Payable
130.20
+33.05%
97.86
-26.00%
132.25
+4.29%
126.81
Current Accrued Expenses
247.52
+15.12%
215.01
-28.09%
299.00
+7.14%
279.07
Employee Benefits
—
20.18
-15.86%
23.99
-23.59%
31.39
Total Tax Payable
18.79
-54.36%
41.16
-0.70%
41.45
+67.58%
24.74
Income Tax Payable
18.79
-54.36%
41.16
-0.70%
41.45
+67.58%
24.74
Current Debt And Capital Lease Obligation
100.00
+0.00%
100.00
+14.29%
87.50
+0.00%
87.50
Current Debt
100.00
+0.00%
100.00
+14.29%
87.50
+0.00%
87.50
Other Current Liabilities
265.51
+35.93%
195.33
+319.64%
46.55
-26.56%
63.38
Total Non Current Liabilities Net Minority Interest
3,060.45
+41.01%
2,170.41
-12.65%
2,484.81
+6.89%
2,324.60
Liabilities Heldfor Sale Non Current
52.97
-52.22%
110.86
—
—
Long Term Debt And Capital Lease Obligation
2,625.66
+59.73%
1,643.83
-10.61%
1,838.87
+5.41%
1,744.46
Long Term Debt
2,541.45
+63.35%
1,555.87
-9.94%
1,727.57
+6.38%
1,624.02
Long Term Capital Lease Obligation
84.21
-4.26%
87.96
-20.97%
111.30
-7.59%
120.44
Non Current Pension And Other Postretirement Benefit Plans
—
20.18
-15.86%
23.99
-23.59%
31.39
Non Current Deferred Liabilities
183.75
-37.81%
295.45
-35.22%
456.08
+17.28%
388.89
Non Current Deferred Taxes Liabilities
183.75
-37.81%
295.45
-35.22%
456.08
+17.28%
388.89
Other Non Current Liabilities
198.07
+64.69%
120.27
-27.49%
165.87
+3.76%
159.86
Stockholders Equity
3,124.77
-26.96%
4,278.14
-3.67%
4,440.99
+10.42%
4,021.97
Common Stock Equity
3,124.77
-26.96%
4,278.14
-3.67%
4,440.99
+10.42%
4,021.97
Capital Stock
48.20
+0.21%
48.10
+0.10%
48.05
+0.19%
47.96
Common Stock
48.20
+0.21%
48.10
+0.10%
48.05
+0.19%
47.96
Share Issued
48.20
+0.21%
48.10
+0.10%
48.05
+0.19%
47.96
Ordinary Shares Number
44.19
-4.49%
46.27
-1.63%
47.04
+0.25%
46.92
Treasury Shares Number
4.00
+119.70%
1.82
+81.11%
1.01
-2.52%
1.03
Additional Paid In Capital
815.81
+4.43%
781.18
+4.20%
749.71
+4.84%
715.12
Retained Earnings
3,149.76
-23.47%
4,115.87
+0.15%
4,109.74
+7.66%
3,817.30
Gains Losses Not Affecting Retained Earnings
-239.47
+24.38%
-316.67
-0.72%
-314.40
+22.08%
-403.52
Treasury Stock
649.53
+85.40%
350.34
+130.33%
152.10
-1.80%
154.89
Other Equity Adjustments
-239.47
+24.38%
-316.67
-0.72%
-314.40
+22.08%
-403.52
Total Equity Gross Minority Interest
3,124.77
-26.96%
4,278.14
-3.67%
4,440.99
+10.42%
4,021.97
Total Capitalization
5,666.22
-2.88%
5,834.01
-5.42%
6,168.56
+9.26%
5,645.99
Working Capital
1,176.31
+43.14%
821.76
+2.64%
800.66
-3.48%
829.49
Invested Capital
5,766.22
-2.83%
5,934.01
-5.15%
6,256.06
+9.11%
5,733.49
Total Debt
2,725.66
+56.30%
1,743.83
-9.48%
1,926.37
+5.15%
1,831.96
Net Debt
2,262.89
+60.71%
1,408.02
-11.57%
1,592.22
+12.17%
1,419.49
Capital Lease Obligations
84.21
-4.26%
87.96
-20.97%
111.30
-7.59%
120.44
Net Tangible Assets
-704.43
-175.14%
937.54
+196.16%
-975.03
-18.77%
-820.93
Tangible Book Value
-704.43
-175.14%
937.54
+196.16%
-975.03
-18.77%
-820.93
Interest Payable
5.40
+1.24%
5.34
-4.39%
5.58
+4.71%
5.33
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
340.68
-46.41%
635.74
+24.50%
510.64
+49.25%
342.14
Cash Flow From Continuing Operating Activities
96.68
-67.97%
301.88
+46.45%
206.14
-39.87%
342.81
Cash From Discontinued Operating Activities
244.00
-26.92%
333.86
+9.64%
304.50
+45889.47%
-0.67
Net Income From Continuing Operations
-905.64
-1399.81%
69.67
-80.45%
356.33
-1.88%
363.14
Depreciation Amortization Depletion
177.74
+10.03%
161.53
+9.07%
148.10
-35.77%
230.59
Depreciation
56.08
+6.31%
52.75
+15.97%
45.49
-31.60%
66.50
Amortization Cash Flow
121.66
+11.84%
108.78
+6.01%
102.62
-37.46%
164.09
Depreciation And Amortization
177.74
+10.03%
161.53
+9.07%
148.10
-35.77%
230.59
Amortization Of Intangibles
121.66
+11.84%
108.78
+6.01%
102.62
-37.46%
164.09
Other Non Cash Items
955.46
+32743.08%
-2.93
+98.85%
-255.05
-1136.80%
-20.62
Pension And Employee Benefit Expense
0.00
-100.00%
132.73
+193.37%
45.24
0.00
Stock Based Compensation
25.70
-1.02%
25.96
-4.91%
27.30
+0.28%
27.22
Asset Impairment Charge
108.12
+1280.10%
7.83
0.00
-100.00%
1.50
Deferred Tax
-100.97
+10.81%
-113.21
-1329.20%
-7.92
+39.11%
-13.01
Deferred Income Tax
-100.97
+10.81%
-113.21
-1329.20%
-7.92
+39.11%
-13.01
Operating Gains Losses
-82.64
-162.26%
132.73
+225.36%
40.80
+774.31%
-6.05
Gain Loss On Investment Securities
-82.64
—
—
—
Change In Working Capital
-45.36
-195.71%
47.40
+155.91%
-84.77
+64.68%
-239.96
Change In Receivables
-85.53
-2273.94%
-3.60
+17.68%
-4.38
+88.62%
-38.46
Changes In Account Receivables
-85.53
-2273.94%
-3.60
+17.68%
-4.38
+88.62%
-38.46
Change In Inventory
84.04
+1145.79%
6.75
+111.95%
-56.44
+49.01%
-110.69
Change In Prepaid Assets
-35.59
-184.92%
41.91
+934.45%
-5.02
-137.42%
13.42
Change In Payables And Accrued Expense
-8.28
-453.11%
2.35
+112.39%
-18.93
+23.64%
-24.79
Change In Payable
-8.28
-453.11%
2.35
+112.39%
-18.93
+23.64%
-24.79
Change In Account Payable
-8.28
-453.11%
2.35
+112.39%
-18.93
+23.64%
-24.79
Change In Other Working Capital
—
-28.49
-132.29%
-12.26
+84.57%
-79.45
Investing Cash Flow
-849.19
-754.68%
-99.36
+84.01%
-621.23
-140.84%
-257.94
Cash Flow From Continuing Investing Activities
-812.65
-1182.58%
-63.36
-332.41%
27.26
+110.51%
-259.41
Cash From Discontinued Investing Activities
-36.54
-1.50%
-36.00
+94.45%
-648.49
-44245.06%
1.47
Capital Expenditure
-95.24
-5.31%
-90.44
-94.82%
-46.42
+41.38%
-79.19
Capital Expenditure Reported
-95.24
-5.31%
-90.44
-94.82%
-46.42
+41.38%
-79.19
Net Investment Purchase And Sale
-5.00
0.00
+100.00%
-4.00
+73.33%
-15.00
Purchase Of Investment
-5.00
+31.51%
-7.30
+35.40%
-11.30
+49.33%
-22.30
Sale Of Investment
0.00
-100.00%
7.30
+0.00%
7.30
+0.00%
7.30
Net Business Purchase And Sale
-825.14
-687520.83%
-0.12
-100.82%
14.55
+107.82%
-186.00
Purchase Of Business
-831.86
-693114.17%
-0.12
+73.33%
-0.45
+99.77%
-198.43
Net Other Investing Changes
91.65
—
—
—
Financing Cash Flow
611.54
+244.94%
-421.93
-1194.77%
38.54
+117.72%
-217.51
Cash Flow From Continuing Financing Activities
611.54
+244.94%
-421.93
-1194.77%
38.54
+117.72%
-217.51
Net Issuance Payments Of Debt
987.00
+711.15%
-161.50
-259.51%
101.25
+172.19%
-140.25
Issuance Of Debt
1,140.00
+776.92%
130.00
-79.88%
646.00
-13.20%
744.25
Repayment Of Debt
-153.00
+47.51%
-291.50
+46.49%
-544.75
+38.41%
-884.50
Long Term Debt Issuance
1,140.00
+776.92%
130.00
-79.88%
646.00
-13.20%
744.25
Long Term Debt Payments
-153.00
+47.51%
-291.50
+46.49%
-544.75
+38.41%
-884.50
Net Long Term Debt Issuance
987.00
+711.15%
-161.50
-259.51%
101.25
+172.19%
-140.25
Net Common Stock Issuance
-300.00
-50.00%
-200.00
0.00
0.00
Common Stock Payments
-300.00
-50.00%
-200.00
0.00
0.00
Common Stock Dividend Paid
—
-63.54
+0.56%
-63.90
-0.17%
-63.79
Cash Dividends Paid
-60.27
+5.15%
-63.54
+0.56%
-63.90
-0.17%
-63.79
Repurchase Of Capital Stock
-300.00
-50.00%
-200.00
0.00
0.00
Proceeds From Stock Option Exercised
7.17
+113.81%
3.35
-35.41%
5.19
+220.47%
-4.31
Net Other Financing Charges
-22.36
-9374.58%
-0.24
+94.11%
-4.00
+56.28%
-9.16
Changes In Cash
103.03
-9.99%
114.45
+258.85%
-72.05
+45.95%
-133.31
Effect Of Exchange Rate Changes
23.17
+340.05%
-9.65
-437.08%
2.86
+114.51%
-19.74
Beginning Cash Position
327.65
+47.03%
222.85
-23.69%
292.03
-34.39%
445.08
End Cash Position
402.68
+41.14%
285.31
+48.04%
192.73
-34.00%
292.03
Free Cash Flow
245.44
-54.99%
545.30
+17.47%
464.22
+76.54%
262.95
Interest Paid Supplemental Data
119.34
+21.31%
98.38
-1.84%
100.22
+41.32%
70.92
Income Tax Paid Supplemental Data
—
164.90
+44.38%
114.21
-29.52%
162.05
Common Stock Issuance
—
—
0.00
0.00
Interest Received CFI
21.08
-22.50%
27.20
-56.92%
63.13
+203.89%
20.77
Issuance Of Capital Stock
—
—
0.00
0.00
Other Cash Adjustment Outside Changein Cash
-51.17
-20.86%
-42.34
-40.57%
-30.12
—
Sale Of Business
6.71
0.00
-100.00%
15.00
+20.64%
12.43
Taxes Refund Paid
-35.73
-31.77%
-27.11
-45.36%
-18.65
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category